Almeida_2023_Maturitas_180_107888

Reference

Title : Dispensing of antineoplastic medications and their impact on the dispensing of anti-dementia drugs for adults aged 60 years: A cohort study - Almeida_2023_Maturitas_180_107888
Author(s) : Almeida OP , Etherton-Beer C , Sanfilippo F , Preen DB , Page A
Ref : Maturitas , 180 :107888 , 2023
Abstract :

History of cancer has been associated with decreased risk of dementia, but it is unclear if this is due to the use of antineoplastic medications. Participants were 442,795 adults aged <=60 years, of whom 235,841 (53.26 %) were women. Those dispensed antineoplastic medications during 2012-2013 had lower odds of being dispensed an anti-dementia drug between 2015 and 2021 (age/sex-adjusted OR = 0.60, 95%CI = 0.55-0.66). The dispensing of antineoplastic medications was associated with an adjusted hazard ratio of 0.72 (95%CI = 0.65-0.80) of subsequent dispensing of an anti-dementia drug. Understanding the mechanisms that support this association may contribute to the introduction of novel approaches to dementia prevention.

PubMedSearch : Almeida_2023_Maturitas_180_107888
PubMedID: 38006816

Related information

Citations formats

Almeida OP, Etherton-Beer C, Sanfilippo F, Preen DB, Page A (2023)
Dispensing of antineoplastic medications and their impact on the dispensing of anti-dementia drugs for adults aged 60 years: A cohort study
Maturitas 180 :107888

Almeida OP, Etherton-Beer C, Sanfilippo F, Preen DB, Page A (2023)
Maturitas 180 :107888